Medical Devices
Specialty & hospital devices — 4 markets side-by-side
Largest Nordic market, regional procurement
Amgros consolidates hospital buying
Non-EU/EEA quirks, Sykehusinnkjøp national
Bilingual labeling, 21 wellbeing counties
| Dimension | Sweden | Denmark | Norway | Finland |
|---|
Need help interpreting the country comparison?
Send your details with your selected sector to ask about the comparison and supporting information. The comparison above remains free to use.
A clear commercial direction for your Nordic growth
Fractio offers bespoke advisory on market priorities, distribution strategy and commercial planning. Scope, deliverables, fees and timing are agreed in a separate proposal.
Consulting is optional and contracted separately from product advertising. Browsing opportunities, contacting advertisers and requesting a basic distributor listing remain free.
Discuss your commercial priorities →How this comparison was built
Data sources. Regulator websites (Läkemedelsverket, Lægemiddelstyrelsen, DMP, Fimea, and sector-specific agencies). Public procurement platforms (Amgros, Sykehusinnkjøp HF, Hansel, Upphandlingsmyndigheten). Fractio's operational experience running B2B2C commercial operations across FMCG, pharma and medical-device sectors. Distributor-concentration numbers reflect market-share reporting from industry associations, OECD, and NSD country reports as of 2025.
Ranges, not points. Distributor margins and lead times are given as ranges because they vary with product complexity, volume and the distributor's own go-to-market posture. Treat the low end of each range as best-case (already-known product, simple regulatory, existing partner) and the high end as realistic for a first-time exporter.
What's not here. Specific tender award values, named competitor pricing, and signed contracts. For any of those, reach out — they're not the kind of thing a public comparison can carry responsibly.
Update cadence. Reviewed quarterly. The 2023 Finnish wellbeing-counties reform and the ongoing MDR/IVDR transitions mean regulatory cells move faster than commercial ones. If you spot something stale, send a correction through our contact page.